SPRY

2.96011.90%
PM

Phillip M. Schneider

Independent Director

Mr. Phillip M. Schneider, also known as Phil, M.B.A, is Director at Longboard Pharmaceuticals, Inc. since December 2020. He served as the Chief Financial Officer of Biogen Idec Inc. (alternate name is IDEC Pharmaceuticals Corporation). During tenure at IDEC, Mr. Schneider served as a Senior Vice President and Chief Financial Officer at Biogen Idec Inc. from 1997 to 2003 and Director of Finance and Administration from 1992 to 1997. He held various positions with IDEC Pharmaceuticals from 1987 to 2003. Prior to his association with IDEC, he held various management positions at Syntex Pharmaceuticals Corporation from 1985 to 1987 and previously worked with KPMG, LLP from 1982 to 1984. He was a Director at Arena Pharmaceuticals, Inc. from December 2007 until June 13, 2018. He was Director of Auspex Pharmaceuticals, Inc. since January 2014 until 2015. He served as a Director of TargeGen, Inc. He served as a Director of Gen-Probe Incorporated since November 2002 until August 1, 2012. He served as a Director of CancerVax Corp. from September 2003 to May 2006. He also served as a Director of Micromet Inc. from September 2003 to November 16, 2007. Mr. Schneider held various management positions at KPMG LLP, an audit and tax advisory firm, from 1982 to 1984, where he attained his CPA license. Mr. Schneider serves as an Independent Director of ARS Pharmaceuticals, Inc., since May 2019 and YMCA of San Diego County since 2002. Mr. Schneider previously served as a member of the board of directors at Pfenex Inc. from 2014 until its acquisition by Ligand Pharmaceuticals in 2020. Mr. Schneider holds an M.B.A. Degree from the University of Southern California and a B.S. in Biochemistry from the University of California at Davis.

公司职务